Cargando…

Antiviral Chemotherapy

Detalles Bibliográficos
Autor principal:	Tamm, Igor
Formato:	Texto
Lenguaje:	English
Publicado:	1956
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2603710/ https://www.ncbi.nlm.nih.gov/pubmed/13361274

Ejemplares similares

Antiviral Chemotherapy
por: Burrell, Christopher J., et al.
Publicado: (2017)

The Future of Antiviral Chemotherapy
por: Crowe, Suzanne, et al.
Publicado: (1988)

Antiviral chemotherapy--a frontier for health and learning.
por: Jackson, G. G.
Publicado: (1982)

Distinct Antiviral Properties of Two Different Bacterial Lysates
por: Roth, Michael, et al.
Publicado: (2021)

Potential of small-molecule fungal metabolites in antiviral chemotherapy
por: Roy, Biswajit G
Publicado: (2017)

Antiviral Drugs, Mode of Action and Chemotherapy of Viral Infections of Man
por: Prusoff, William H.
Publicado: (1977)

William H. Prusoff (1920–2011): Father of Antiviral Chemotherapy
por: Cheng, Yung-Chi
Publicado: (2011)

BENZIMIDAZOLE DERIVATIVES: NEW ENHANCERS OF INFLUENZA VIRUS MULTIPLICATION
por: Tamm, Igor
Publicado: (1973)

Inhibitors of Nucleotide Biosynthesis as Candidates for a Wide Spectrum of Antiviral Chemotherapy
por: Sepúlveda, Claudia Soledad, et al.
Publicado: (2022)

Immune checkpoint inhibitors modulate the cytotoxic effect of chemotherapy in lung adenocarcinoma cells
por: Saar, Marika, et al.
Publicado: (2023)

Differential decay kinetics of human cytomegalovirus glycoprotein B genotypes following antiviral chemotherapy()
por: Emery, Vincent C., et al.
Publicado: (2012)

Antivirals and antiviral strategies
por: Clercq, Erik De
Publicado: (2004)

ON THE ROLE OF RIBONUCLEIC ACID IN ANIMAL VIRUS SYNTHESIS : II. STUDIES WITH RIBONUCLEASE
por: Tamm, Igor, et al.
Publicado: (1960)

DNA REPLICATION: DIRECTION AND RATE OF CHAIN GROWTH IN MAMMALIAN CELLS
por: Hand, Roger, et al.
Publicado: (1973)

Antiviral Therapy of COVID-19
por: Gudima, Georgii, et al.
Publicado: (2023)

ENUMERATION OF CELL-INFECTING PARTICLES OF NEWCASTLE DISEASE VIRUS BY THE FLUORESCENT ANTIBODY TECHNIQUE
por: Wheelock, E. Frederick, et al.
Publicado: (1961)

EFFECT OF MULTIPLICITY OF INFECTION ON NEWCASTLE DISEASE VIRUS-HELA CELL INTERACTION
por: Wheelock, E. Frederick, et al.
Publicado: (1961)

SPECTRUM AND CHARACTERISTICS OF THE VIRUS INHIBITORY ACTION OF 2-(α-HYDROXYBENZYL)-BENZIMIDAZOLE
por: Eggers, Hans J., et al.
Publicado: (1961)

STUDIES OF TWO KINDS OF VIRUS PARTICLES WHICH COMPRISE INFLUENZA A2 VIRUS STRAINS : II. REACTIVITY WITH VIRUS INHIBITORS IN NORMAL SERA
por: Choppin, Purnell W., et al.
Publicado: (1960)

STUDIES OF TWO KINDS OF VIRUS PARTICLES WHICH COMPRISE INFLUENZA A2 VIRUS STRAINS : I. CHARACTERIZATION OF STABLE HOMOGENEOUS SUBSTRAINS IN REACTIONS WITH SPECIFIC ANTIBODY, MUCOPROTEIN INHIBITORS, AND ERYTHROCYTES
por: Choppin, Purnell W., et al.
Publicado: (1960)

BIOCHEMICAL BASIS FOR ALTERATIONS IN STRUCTURE AND FUNCTION OF HELA CELLS INFECTED WITH NEWCASTLE DISEASE VIRUS
por: Wheelock, E. Frederick, et al.
Publicado: (1961)

A MUCOPROTEIN DERIVED FROM HUMAN URINE WHICH REACTS WITH INFLUENZA, MUMPS, AND NEWCASTLE DISEASE VIRUSES
por: Tamm, Igor, et al.
Publicado: (1952)

Hedging against Antiviral Resistance during the Next Influenza Pandemic Using Small Stockpiles of an Alternative Chemotherapy
por: Wu, Joseph T., et al.
Publicado: (2009)

INFLUENZA VIRUS MULTIPLICATION IN THE CHORIOALLANTOIC MEMBRANE IN VITRO: KINETIC ASPECTS OF INHIBITION BY 5, 6-DICHLORO-1-β-D-RIBOFURANOSYLBENZIMIDAZOLE
por: Tamm, Igor, et al.
Publicado: (1954)

Fulminant parvovirus B19 myocarditis after chemotherapy: full recovery after antiviral therapy with tenofovir
por: Koenig, Tobias, et al.
Publicado: (2021)

Antiviral antibody responses to systemic administration of an oncolytic RNA virus: the impact of standard concomitant anticancer chemotherapies
por: Roulstone, Victoria, et al.
Publicado: (2021)

Zika antiviral chemotherapy: identification of drugs and promising starting points for drug discovery from an FDA-approved library
por: Pascoalino, Bruno S., et al.
Publicado: (2016)

Inhibition of Influenza Virus Multiplication by 2,5-Dimethylbenzimidazole
por: Tamm, Igor, et al.
Publicado: (1952)

ON THE ROLE OF RIBONUCLEIC ACID IN ANIMAL VIRUS SYNTHESIS : I. STUDIES WITH 5,6-DICHLORO-1-β-D-RIBOFURANOSYLBENZIMIDAZOLE
por: Tamm, Igor, et al.
Publicado: (1960)

STUDIES OF TWO KINDS OF VIRUS PARTICLES WHICH COMPRISE INFLUENZA A2 VIRUS STRAINS : III. MORPHOLOGICAL CHARACTERISTICS: INDEPENDENCE OF MORPHOLOGICAL AND FUNCTIONAL TRAITS
por: Choppin, Purnell W., et al.
Publicado: (1960)

INHIBITION OF INFLUENZA VIRUS MULTIPLICATION BY ALKYL DERIVATIVES OF BENZIMIDAZOLE : I. KINETIC ASPECTS OF INHIBITION BY 2,5-DIMETHYLBENZIMIDAZOLE AS MEASURED BY INFECTIVITY TITRATIONS
por: Tamm, Igor, et al.
Publicado: (1953)

INHIBITION OF INFLUENZA VIRUS MULTIPLICATION BY ALKYL DERIVATIVES OF BENZIMIDAZOLE : II. MEASUREMENT OF INHIBITORY ACTIVITY BY HEMAGGLUTINATION TITRATIONS
por: Tamm, Igor, et al.
Publicado: (1953)

Antiviral Effects of Animal Toxins: Is There a Way to Drugs?
por: Utkin, Yuri, et al.
Publicado: (2022)

Hepatitis B virus reactivation and antiviral prophylaxis during lung cancer chemotherapy: A systematic review and meta-analysis
por: Wu, Yu-tuan, et al.
Publicado: (2017)

A Novel Antiviral Treatment of Hepatitis C Virus Reactivation in a Breast Cancer Patient Undergoing Chemotherapy
por: Wu, Yu-Tuan, et al.
Publicado: (2017)

Effects of Antiviral Therapy on HBV Reactivation and Survival in Hepatocellular Carcinoma Patients Undergoing Hepatic Artery Infusion Chemotherapy
por: Liu, Shousheng, et al.
Publicado: (2021)

Correction: Antiviral antibody responses to systemic administration of an oncolytic RNA virus: the impact of standard concomitant anticancer chemotherapies
Publicado: (2022)

Broad-Spectrum Antivirals and Antiviral Drug Combinations
por: Oksenych, Valentyn, et al.
Publicado: (2022)

AN ELECTROPHORETIC EXAMINATION OF A URINARY MUCOPROTEIN WHICH REACTS WITH VARIOUS VIRUSES
por: Perlmann, Gertrude E., et al.
Publicado: (1952)

Advances in Antiviral Delivery Systems and Chitosan-Based Polymeric and Nanoparticulate Antivirals and Antiviral Carriers
por: Žigrayová, Dominika, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_65gk4u60dqck6omlbfvfrr3njh